Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
Executive Decision Statement Decision: I will initiate an immediate voluntary safety update and regulatory disclosure. I will reject the legal team's "6-month delay" strategy and the board's "wait for data" directive. Delaying disclosure of a known, serious safety signal constitutes fraud in many jurisdictions.Read the full answer